Prevalence
Clinical
features
Differential
Diagnosis
Investigations
Therapy
Prevention
Prognosis
|  |  | | Therapy |
Consider non-invasive ventilation a
b
for patients with respiratory failure: a
- tachypnoea: rate 23 per minute or more
- pH 7.25 to 7.35 with pCO2 > 6 kPa
Why?
-
Non-invasive positive pressure ventilation reduces need for endotracheal intubation and death
a
b
and helps reduce days on mechanical ventilation if used as an adjunct to weaning (on average 6 days)
a
-
However complications are common. These include facial skin abrasions
or necrosis (2.1% to 21%), pneumonia (0.6% to 5.5%), retention of
secretions (0% to 17%), conjunctivitis (0% to 14%), and gastric
distention (0% to 3%). a
-
Facial masks are better tolerated than nasal masks. They cause more
facial necrosis and gastric distention, but less conjunctivitis than
nasal masks. a
-
Ventillatory support and aggressive care is poorly cost-effective for
high-risk patients (> 50% chance of dying within 2 months)
with acute respiratory failure. a
Non-invasive ventilation reduces intubation and death in severe cases
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
acute exacerbation of COPD
b
|
non-invasive ventilation
|
no ventilation
|
required endotracheal intubation
|
74%
|
65%
(40% to
80%)
|
2
(1 to
3)
|
|
|
|
|
death
at
weeks
|
26%
|
67%
(7% to
89%)
|
5
(3 to
32)
|
COPD on mechanical ventilation
a
|
non-invasive ventilation weaning
|
standard weaning
|
failure to wean
|
52%
|
69%
(19% to
88%)
|
3
(2 to
9)
|
|